Informações:
Falhas:
ID
29954
Descrição
A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00770861
Link
https://clinicaltrials.gov/show/NCT00770861
Palavras-chave
Versões (1)
- 29/04/18 29/04/18 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
29 aprile 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hypertension NCT00770861
Eligibility Hypertension NCT00770861
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00770861
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Outpatients | Age | Hispanics | Latinos
Item
male and female outpatients 18 to 80 years of age, self-identified as hispanic or latino ethnicity
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0086409 (UMLS CUI [3])
C0086528 (UMLS CUI [4])
C0001779 (UMLS CUI [2])
C0086409 (UMLS CUI [3])
C0086528 (UMLS CUI [4])
Postmenopausal state | Gender Pregnancy Absent | Gender Contraceptive methods
Item
females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
boolean
C0232970 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0079399 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Hypertensive disease Stage
Item
meet criteria for stage i or ii hypertension
boolean
C0020538 (UMLS CUI [1,1])
C0699749 (UMLS CUI [1,2])
C0699749 (UMLS CUI [1,2])
Therapeutic procedure Absent | Antihypertensive Agents Quantity
Item
currently not treated, or being treated with no more than two anti-hypertensive medications
boolean
C0087111 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0003364 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0332197 (UMLS CUI [1,2])
C0003364 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Secondary hypertension
Item
secondary hypertension
boolean
C0155616 (UMLS CUI [1])
Antihypertensive Agents Quantity
Item
are taking three or more antihypertensive agents
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
DIABETES MELLITUS INSULIN DEPENDENT UNCONTROLLED | DIABETES MELLITUS NON INSULIN DEPENDENT UNCONTROLLED | Insulin-Dependent Diabetes Mellitus Poorly controlled | Non-Insulin-Dependent Diabetes Mellitus Poorly controlled
Item
have uncontrolled or poorly controlled diabetes mellitus type i or type ii
boolean
C0743113 (UMLS CUI [1])
C0743118 (UMLS CUI [2])
C0011854 (UMLS CUI [3,1])
C3853134 (UMLS CUI [3,2])
C0011860 (UMLS CUI [4,1])
C3853134 (UMLS CUI [4,2])
C0743118 (UMLS CUI [2])
C0011854 (UMLS CUI [3,1])
C3853134 (UMLS CUI [3,2])
C0011860 (UMLS CUI [4,1])
C3853134 (UMLS CUI [4,2])
Comorbidity Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
evidence of other concurrent disease or conditions that might interfere with the conduct of the study
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Study Subject Participation Status
Item
participation in any investigational study within 30 days of screening (visit 1).
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Nebivolol | BETA BLOCKER ALLERGY | Medical contraindication Adrenergic beta-1 Receptor Antagonists
Item
have a history of hypersensitivity to nebivolol or other β-blockers, or any contraindication to β-blocker use
boolean
C0020517 (UMLS CUI [1,1])
C0068475 (UMLS CUI [1,2])
C0741466 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0304516 (UMLS CUI [3,2])
C0068475 (UMLS CUI [1,2])
C0741466 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0304516 (UMLS CUI [3,2])